Short research communication viscerotropic potential of parasites isolated from post-Kala-Azar dermal leishmaniasis cases: An experimental evidence

Journal of Vector Borne Diseases

Volumn 49, Issue 4, 2012, Pages 266-267

  Gupta, A K ^a   Narayan, S ^a   Verma, N ^a   Thakur, A K ^a   Das, P ^a  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

India; Leishmania donovani; Leishmaniasis; Viscerotropism

Indexed keywords

AMASTIGOTE; ARTICLE; DISEASE ASSOCIATION; EXPERIMENTAL MOUSE; LEISHMANIA DONOVANI; LIVER BIOPSY; MEDICAL RESEARCH; MICROSCOPY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE ISOLATION; POST KALA AZAR DERMAL LEISHMANIASIS; PROMASTIGOTE; SKIN LEISHMANIASIS; SPLEEN BIOPSY; STAINING; VISCERAL LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; COMPLICATION; HUMAN; ISOLATION AND PURIFICATION; MOUSE; PARASITOLOGY; PATHOGENICITY; SKIN DISEASES; SPLEEN; SKIN DISEASE;

ANIMALS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; SKIN DISEASES; SPLEEN;

EID: 84873660929     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Thakur CP. Review on current status of leishmaniasis: Clinical and laboratory diagnosis. Proceedings of the Indo-UK Workshop on Leishmaniasis. New Delhi: Indian Council of Medical Research 1983; p. 50-55.
2. Zijlstra EE, El-Hassan AM, Ismael A. Endemic kalaazar in eastern Sudan: Post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 1995; 52: 299-305.
3. Control of the leishmaniases: Report of a meeting of the WHO Expert Committee on the control of leishmaniases. Geneva: World Health Organization 2010. WHO Tech Rep Ser 949.
4. El-masum MA, Evans DA. Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leish maniasis in Bangladesh. Trans R Soc Trop Med Hyg 1995; 89: 331-332.
5. Nandy A, Addy M, Maji AK, Guha SK, Banerjee D, Chaudhri D. Recurrence of kala-azar after PKDL: Role of co-factors. Trop Med Int Health 1998; 3: 76-78.
6. Garg VK, Agarwal S, Rani S, Joshi A, Agarwalla A, Das ML, et al. Post kala-azar dermal leishmaniasis in Nepal. Int J Dermatol 2001; 40: 179-84.
7. Zijlstra EE, El-Hassan AM. Leishmaniasis in Sudan: Visceral leish maniasis. Trans R Soc Trop Med Hyg 2001; 95 (Suppl 1): S27-S58.
8. Meredith SEO, Zijlstra EE, Schoone GJ, Kroon CCM, vans Eys GJJM, Schaeffer KU, et al. Development of the polymerase chain reaction for the detection and identification of leishmania parasites, and the application of the PCR for detection of parasites in clinical material. Arch Inst Pasteur Tunis 1993; 70: 419-431.
9. Thakur CP, Kumar K. Post-kala-azar dermal leishmaniasis: A neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 1992; 86: 355-359.
10. Sharma NL, Mahajan VK, Kanga A, Sood A, Katoch VM, et al. Localized cutaneous leishmanisis due to Leishmania donovani and Leishmania tropica: Preliminary. Trans R Soc Trop Med Hyg 2005; 72(6): 819-824.
11. Karunaweera ND, Pratlong F, Siriwardane HV, Ihalamulla RL, Dedet JP. Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Trans R Soc Trop Med Hyg 2003; 97: 380-381.
12. Mebrahtu YB, Eys GV, Guizani I, Lawyer PG, Pamba H, Koech D. Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya. Trans R Soc Trop Med Hyg 1993; 87(5): 598-601.